QQQ   302.97 (-1.85%)
AAPL   116.86 (-3.76%)
MSFT   229.14 (-1.06%)
FB   257.72 (-2.48%)
GOOGL   2,038.00 (-2.82%)
TSLA   569.12 (-4.82%)
AMZN   2,987.89 (-0.42%)
NVDA   468.62 (-5.99%)
BABA   227.80 (-2.60%)
CGC   31.13 (-0.13%)
GE   14.11 (+3.75%)
MU   85.65 (-3.69%)
NIO   35.64 (-6.48%)
AMD   75.18 (-4.25%)
T   30.25 (+2.13%)
F   12.55 (+2.28%)
ACB   9.60 (+0.00%)
DIS   197.85 (+4.14%)
BA   224.94 (+0.77%)
NFLX   501.94 (-2.80%)
PFE   34.71 (+0.93%)
QQQ   302.97 (-1.85%)
AAPL   116.86 (-3.76%)
MSFT   229.14 (-1.06%)
FB   257.72 (-2.48%)
GOOGL   2,038.00 (-2.82%)
TSLA   569.12 (-4.82%)
AMZN   2,987.89 (-0.42%)
NVDA   468.62 (-5.99%)
BABA   227.80 (-2.60%)
CGC   31.13 (-0.13%)
GE   14.11 (+3.75%)
MU   85.65 (-3.69%)
NIO   35.64 (-6.48%)
AMD   75.18 (-4.25%)
T   30.25 (+2.13%)
F   12.55 (+2.28%)
ACB   9.60 (+0.00%)
DIS   197.85 (+4.14%)
BA   224.94 (+0.77%)
NFLX   501.94 (-2.80%)
PFE   34.71 (+0.93%)
QQQ   302.97 (-1.85%)
AAPL   116.86 (-3.76%)
MSFT   229.14 (-1.06%)
FB   257.72 (-2.48%)
GOOGL   2,038.00 (-2.82%)
TSLA   569.12 (-4.82%)
AMZN   2,987.89 (-0.42%)
NVDA   468.62 (-5.99%)
BABA   227.80 (-2.60%)
CGC   31.13 (-0.13%)
GE   14.11 (+3.75%)
MU   85.65 (-3.69%)
NIO   35.64 (-6.48%)
AMD   75.18 (-4.25%)
T   30.25 (+2.13%)
F   12.55 (+2.28%)
ACB   9.60 (+0.00%)
DIS   197.85 (+4.14%)
BA   224.94 (+0.77%)
NFLX   501.94 (-2.80%)
PFE   34.71 (+0.93%)
QQQ   302.97 (-1.85%)
AAPL   116.86 (-3.76%)
MSFT   229.14 (-1.06%)
FB   257.72 (-2.48%)
GOOGL   2,038.00 (-2.82%)
TSLA   569.12 (-4.82%)
AMZN   2,987.89 (-0.42%)
NVDA   468.62 (-5.99%)
BABA   227.80 (-2.60%)
CGC   31.13 (-0.13%)
GE   14.11 (+3.75%)
MU   85.65 (-3.69%)
NIO   35.64 (-6.48%)
AMD   75.18 (-4.25%)
T   30.25 (+2.13%)
F   12.55 (+2.28%)
ACB   9.60 (+0.00%)
DIS   197.85 (+4.14%)
BA   224.94 (+0.77%)
NFLX   501.94 (-2.80%)
PFE   34.71 (+0.93%)
Log in
NASDAQ:KRYS

Krystal Biotech SEC Filings & 10K Form

$70.80
-1.94 (-2.67 %)
(As of 03/8/2021 01:58 PM ET)
Add
Compare
Today's Range
$70.62
Now: $70.80
$75.24
50-Day Range
$66.34
MA: $72.49
$85.46
52-Week Range
$33.08
Now: $70.80
$87.29
Volume3,901 shs
Average Volume172,314 shs
Market Capitalization$1.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.2

SEC Filings

Krystal Biotech (NASDAQ:KRYS) SEC Filings

DateFilerForm TypeView
03/02/2021
7:42 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:40 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:39 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:15 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
3:27 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/12/2021
3:55 PM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/05/2021
3:39 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
3:35 PM
Frazier Life Sciences IX, L.P. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/02/2021
3:13 PM
Krystal Biotech (Filer)
Form 424B5
01/22/2021
3:51 PM
Krystal Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/07/2021
7:02 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
4:14 PM
Krystal Biotech (Issuer)
Marantz Jing L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
7:15 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
4:28 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
3:39 PM
Krystal Biotech (Filer)
Form 424B5
11/09/2020
7:32 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
3:06 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
5:35 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
7:10 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
7:43 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:22 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:10 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
3:17 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
3:10 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
4:16 PM
Krystal Biotech (Filer)
Form 424B2
05/19/2020
4:01 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:28 PM
Krystal Biotech (Filer)
Form 424B5
05/14/2020
7:05 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:45 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
8:42 AM
Krystal Biotech (Filer)
Form S-3ASR
05/04/2020
7:05 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:12 PM
Krystal Biotech (Filer)
Form DEF 14A
03/18/2020
7:14 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
10:16 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
7:00 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2020
4:27 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
4:27 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:15 AM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
02/14/2020
4:12 PM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
02/14/2020
3:14 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/14/2020
3:13 PM
Krishnan Krish S (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
01/31/2020
5:37 PM
Chien Jennifer (Reporting)
Krystal Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2019
4:56 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:05 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:03 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
8:58 PM
Krystal Biotech (Filer)
Form 8-K/A
11/04/2019
7:01 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
7:00 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
7:06 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
4:23 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
11:01 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
8:23 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2019
3:28 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
3:47 PM
Krystal Biotech (Filer)
Form 424B5
06/24/2019
3:34 PM
Krystal Biotech (Filer)
Form 424B5
06/24/2019
7:08 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
4:24 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
2:34 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:15 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
8:20 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2019
3:07 PM
Krystal Biotech (Filer)
Form DEFA14A
04/15/2019
3:03 PM
Krystal Biotech (Filer)
Form DEF 14A
03/25/2019
8:07 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
5:06 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
8:36 AM
Krystal Biotech (Filer)
Form 424B5
03/12/2019
8:28 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
7:12 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:06 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:53 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
4:51 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2019
3:44 PM
Krishnan Krish S (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/19/2019
3:40 PM
Krishnan Suma (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/14/2019
4:13 PM
Krystal Biotech (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2019
12:39 PM
Frazier Life Sciences IX, L.P. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G
11/05/2018
9:20 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
8:00 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2018
3:07 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
4:28 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2018
4:27 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2018
4:27 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
4:27 PM
Krystal Biotech (Filer)
Form 424B5
10/17/2018
4:07 PM
Krystal Biotech (Filer)
Form 424B5
10/15/2018
7:44 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2018
11:15 PM
Krystal Biotech (Filer)
Form EFFECT
10/01/2018
11:27 AM
Krystal Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/27/2018
2:10 PM
Frazier Life Sciences IX, L.P. (Filed by)
Krystal Biotech (Subject)
Form SC 13G
08/17/2018
1:11 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
8:13 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2018
3:08 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:01 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:00 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
6:43 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:53 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:49 PM
Krystal Biotech (Issuer)
NORBY R DOUGLAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2018
11:16 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
4:28 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
4:26 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/11/2018
3:27 PM
Krystal Biotech (Issuer)
NORBY R DOUGLAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:34 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.